EVH

Evolent Health, Inc Class A Common Stock

3.23

USD

EVH Earnings Reports

Positive Surprise Ratio

EVH beat 30 of 40 last estimates.

75%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$473.39M

$0.05

Implied change from Q3 25 (Revenue/ EPS)

-1.28%

Implied change from Q4 24 (Revenue/ EPS)

-26.78%

-350.00%

Evolent Health, Inc Class A Common Stock earnings per share and revenue

On Nov 06, 2025, EVH reported earnings of 0.05 USD per share (EPS) for Q3 25, missing the estimate of 0.10 USD, resulting in a -52.61% surprise. Revenue reached 479.53 million, compared to an expected 472.17 million, with a 1.56% difference. The market reacted with a -17.33% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 16 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 473.39 million USD, implying an increase of 0.00% EPS, and decrease of -1.28% in Revenue from the last quarter.

FAQ

What were Evolent Health, Inc Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Evolent Health, Inc Class A Common Stock reported EPS of $0.05, missing estimates by -52.61%, and revenue of $479.53M, 1.56% above expectations.

How did the market react to Evolent Health, Inc Class A Common Stock's Q3 2025 earnings?

The stock price moved down -17.33%, changed from $6.00 before the earnings release to $4.96 the day after.

When is Evolent Health, Inc Class A Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Evolent Health, Inc Class A Common Stock's next earnings report?

Based on 16 analysts, Evolent Health, Inc Class A Common Stock is expected to report EPS of $0.05 and revenue of $473.39M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.